Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator.

Slides:



Advertisements
Similar presentations
Derivation of initial electron beam energy spectrum Janusz Harasimowicz Establishment for Nuclear Equipment
Advertisements

Stefan Roesler SC-RP/CERN on behalf of the CERN-SLAC RP Collaboration
The Vin č a Institute of Nuclear Sciences, Belgrade, Serbia * Universita degli studi di Bologna, DIENCA, Italia Radovan D. Ili}, Milan Pe{i}, Radojko Pavlovi}
GEANT4 simulation of an ocular proton beam & benchmark against MC codes D. R. Shipley, H. Palmans, C. Baker, A. Kacperek Monte Carlo 2005 Topical Meeting.
FREDONE, A PROJECT ON DOSIMETRY OF HIGH ENERGY NEUTRONS Valérie De Smet (1), Isabelle Gerardy (2), Fréderic Stichelbaut (3), (1) IRISIB, Département nucléaire,
Experience, Expertise and a Commitment to Excellence™
Radiotherapy Planning Stephen C. Billups University of Colorado at Denver
Dose Calculations A qualitative overview of Empirical Models and Algorithms Hanne Kooy.
MONTE-CARLO TECHNIQUES APPLIED TO PROTON DOSIMETRY AND RADIATION SAFETY F. Guillaume, G. Rucka, J. Hérault, N. Iborra, P. Chauvel 1 XXXV European Cyclotron.
Using FLUKA to study Radiation Fields in ERL Components Jason E. Andrews, University of Washington Vaclav Kostroun, Mentor.
Optimisation of X-ray micro-tomography to perform low-dose imaging of highly-dosed gels P.M.Jenneson, E.C.Atkinson, P.Wai and S.J.Doran In 1993, Maryanski.
Reduced Dose of Proton CT Compared to X-Ray CT in Tissue-Density Variation Sensitivity T. Satogata, T. Bacarian, S. Peggs, A.G. Ruggiero, and F.A. Dilmanian.
Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.
Tissue inhomogeneities in Monte Carlo treatment planning for proton therapy L. Beaulieu 1, M. Bazalova 2,3, C. Furstoss 4, F. Verhaegen 2,5 (1) Centre.
At the position d max of maximum energy loss of radiation, the number of secondary ionizations products peaks which in turn maximizes the dose at that.
BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,
Dose Distribution and Scatter Analysis
A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.
PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme Charged Particle Therapy Treating cancer with protons and light ions Ken Peach,
Научно-практический центр протонной лучевой терапии и радиохирургии (Москва-Дубна) A SYSTEM FOR MEASUREMENT OF A THERAPEUTIC PROTON BEAM DOSE DISTRIBUTION.
SOI detector Geant4-based studies to characterise the tissue-equivalence of SOI and diamond microdosimeteric detectors, under development at CMRP S. Dowdell,
Applications of Geant4 in Proton Radiotherapy at the University of Texas M.D. Anderson Cancer Center Jerimy C. Polf Assistant Professor Department of Radiation.
Preliminarily results of Monte Carlo study of neutron beam production at iThemba LABS University of the western cape and iThemba LABS Energy Postgraduate.
G. Bartesaghi, 11° ICATPP, Como, 5-9 October 2009 MONTE CARLO SIMULATIONS ON NEUTRON TRANSPORT AND ABSORBED DOSE IN TISSUE-EQUIVALENT PHANTOMS EXPOSED.
Bragg Peak By: Megan Whitley. Bragg Peak  Bragg Peak is the characteristic exhibited by protons that makes them SO appealing for cancer treatment. 
16 th International Congress on Neutron Capture Therapy June 14-19, Helsinki, Finland Improvement of a PGNAA Facility for BNCT in THOR C. K. Huang 1, H.
Ian C. Smith 1 A portal-based system for quality assurance of radiotherapy treatment plans using Grid-enabled High Performance Computing clusters CR Baker.
Dose distribution assessment in human eye proton therapy by Monte Carlo method 1 Department of Physics, Faculty of Science, University of Isfahan, Isfahan,
1 Dr. Sandro Sandri (President of Italian Association of Radiation Protection, AIRP) Head, Radiation Protection Laboratory, IRP FUAC Frascati ENEA – Radiation.
Medical Accelerator F. Foppiano, M.G. Pia, M. Piergentili
APPLICATION TO THE HADROTHERAPY FOR OCULAR MELANOMAS G.A. Pablo Cirrone Qualified Medical Physicist and PhD Student University of Catania and Laboratori.
1 Radiotherapy, hadrontherapy and treatment planning systems. Faiza Bourhaleb INFN-Torino University Med 1er-Morocco  Radiotherapy  Optimization techniques.
Integrated Radiation Measurement and Radiation Protection of BES Ⅲ Zhang Qingjiang, Wu protection group, accelerator center, IHEP,
Managed by UT-Battelle for the Department of Energy Residual Does Rate Analyses for the SNS Accelerator Facility I. Popova, J. Galambos HB2008 August 25-29,
Shielding Measurements For A Proton Therapy Facility S. Avery, K. P. Risolo, M. Bartels, C. Ainsley, J McDonough, R. L. Maughan University of Pennsylvania.
Improvement of the Monte Carlo Simulation Efficiency of a Proton Therapy Treatment Head Based on Proton Tracking Analysis and Geometry Simplifications.
Gate-simulation of dose G4: David Nokto & Anette Kniberg.
Neutron measurement with nuclear emulsion Mitsu KIMURA 27th Feb 2013.
1 Neutron Effective Dose calculation behind Concrete Shielding of Charge Particle Accelerators with Energy up to 100 MeV V. E Aleinikov, L. G. Beskrovnaja,
An introduction Luisella Lari On behalf of the FLUKA collaboration CAoPAC: Computer-Aided Optimization of Particle Accelerator Workshop March 2015.
ESTRO, Geneva 2003 The importance of nuclear interactions for dose calculations in proton therapy M.Soukup 1, M.Fippel 2, F. Nuesslin 2 1 Department of.
If information seems to be missing, make any reasonable assumptions. 1.A target has an areal density of 2.3 g/cm 2 and a thickness of 0.8 inch. What is.
A Proton Therapy Overview Richard Eckart And David Turberville Richard Eckart And David Turberville.
The Australian Hadron Therapy and Research Facility.
Se Byeong Lee, Ph.D Chief Medical Physicist Proton Therapy Center in NCC, Korea.
Development of elements of 3D planning program for radiotherapy Graphical editor options  automated enclose of contour  correction of intersections 
Beam dynamics and linac optics studies for medical proton accelerators
Achim Stahl RWTH Aachen Hadron Therapy, Jülich Oct, Workshop Nuclear Models for Use in Hadron Therapy October 8./ Achim Stahl – RWTH Aachen.
Understanding Radiation Therapy Lecturer Radiological Science
Primary Radiation Calculation for Sun Yat-Sen Proton Hospital
BDSIM for proton therapy gantry simulation
Radiological Protection in Ion Beam Radiotherapy
INTERCOMPARISON P3. Dose distribution of a proton beam
Electron Beam Therapy.
EURADOS Working Group 9: Radiation Dosimetry in Radiotherapy
Very High Energy Electron for Radiotherapy Studies
Beam diagnostics for medical accelerators
A Comparative Study of Biological Effects of VHEE, Protons and other Radiotherapy Modalities Kristina Small University of Manchester, Christie NHS Foundation.
Development and characterization of the Detectorized Phantom for research in the field of spatial fractionated radiation therapy. D. Ramazanov, V. Pugatch,
Arghya Chattaraj, T. Palani Selvam, D. Datta
M. D. Anderson Cancer Center Houston, TX
Witold Matysiak (University of Florida Proton Therapy Institute)
Radiosurgical Management of Brain Metastases
Radiation Shielding Val Kostroun REU Presentation, June 1, 2009
APPLICATION TO THE HADROTHERAPY FOR OCULAR MELANOMAS
By: Vi Nhan Nguyen University of Arizona
Geant4 at IST Applications in Brachytherapy
Innovations in the Radiotherapy of Non–Small Cell Lung Cancer
Sheng Yang a, Yen-Wan Hsueh Liu b
Presentation transcript:

Energy deposition and neutron background studies for a low energy proton therapy facility Roxana Rata*, Roger Barlow* * International Institute for Accelerator Applications (IIAA) Abstract Proton therapy is important in the fight agains cancer, because the Bragg peak delivers the dose within the tumour and spares the surrounding tissue. Proton beams from cyclotrons are delivered through passive scattering which requires several studies to calculate the dose in the tumour and in the surrounding tissue. For this study, using FLUKA Monte Carlo code, we simulated a 60 MeV proton beam used to treat ocular tumours at Clatterbridge Centre for Oncology. Many elements of the beam line, such as : nozzle, collimator, water phantom, were modelled. A simple geometry was considered for this set of simulations. The proton energy deposition and the proton fluence in the water phantom were studied, together with secondary neutron energy deposition and secondary neutron fluence for a better understanding of the contribution of the total dose in the target volume. 1. Introduction and Objectives 2. Methods 3. Results The main challenge of conventional radiotherapy is to minimize the dose to healthy tissue. Proton therapy has this advantage of sparing the surrounding organs, reducing the side effects. The proton beams are mainly delivered through passive scattering which causes beam loss in the beam line components, therefore secondary neutron radiation is produced. The neutrons generated during treatment can contribute to the total dose in the target volume and far beyond. The purpose of this work is to calculate and study the dose for protons and also the secondary neutron fluence and the neutron dose in patients, by performing Monte Carlo simulations for Clatterbridge Centre for Oncology. The simulations were performed with FLUKA Monte Carlo code. FLUKA is a powerful tool which can be also used in high-energy physics, shielding, dosimetry, calorimetry etc. The beam used in this simulation was a 60 MeV proton beam. A simple geometry was considered for this initial work: the nozzle, the patient collimator and a water phantom. The proton and the neutron dose and fluence were calculated in the water phantom which simulates the eye tissue (Fig. 1). Fig.1 3D- View of the simulation geometry Fig.2 Neutron fluence in the nozzle Fig.3 Neutron fluence in the water phantom Fig.4 Proton fluence in the nozzle Fig.5 Proton dose in the water phantom The results of the neutron fluence in the nozzle and in the water phantom are plotted in Fig.2 and Fig.3 as function of the depth. It can be seen that the neutron fluence reaches a maximum at the exit of the nozzle, and at the entrance of the water phantom. Fig. 4 represents the proton fluence along the nozzle. Fig. 5 plots the proton dose deposited in the water phantom. The Bragg peak (maximum value) was found at 3 cm depth. As the beam is completely stopped, only secondaries deliver a dose in the rest of the water phantom. Contacts: